VA launches MDMA trial years in the making for veterans
The randomized study will test whether MDMA-assisted psychotherapy can improve symptoms using pharmaceutical-grade doses and an active placebo.
- On Tuesday, the U.S. Department of Veterans Affairs launched a clinical trial testing MDMA-assisted therapy for veterans with PTSD and alcohol use disorder, one of 19 psychedelic studies the agency is funding through $23 million in external grants.
- President Donald Trump's April 18 executive order directing federal agencies to expand psychedelic research prompted the initiative, citing more than 6,000 veteran suicides annually—more than twice the non-veteran rate.
- Participants will be randomly assigned to receive MDMA-assisted psychotherapy or the same therapy with an active placebo using pharmaceutical-grade MDMA, a Schedule I controlled substance researchers say may increase emotional processing during treatment.
- VA Secretary Doug Collins said the trial reflects an "all-of-the-above strategy" for mental health, and the VA pledged to coordinate with the FDA and share data, though many veterans with severe presentations may not qualify due to eligibility restrictions.
- Results won't arrive until May 2030, with Dr. Lynnette Averill, chief science officer of Reason for Hope and the Veterans Mental Health Leadership Coalition, noting the lengthy timeline from December 2024 funding to trial launch; skeptics including Kevin A. Sabet, president and CEO of Smart Approaches to Marijuana, raised unresolved safety concerns from the FDA's 2024 rejection.
38 Articles
38 Articles
![[your]NEWS](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Ffb6dc495f74049f513563c33352175eaa0ecd509.jpg%3Fwidth%3D24&w=64&q=75){kind=small}
VA launches MDMA trial years in the making for veterans
(The Center Square) – The U.S. Department of Veterans Affairs on Tuesday launched a clinical trial testing MDMA-assisted therapy for veterans with post-traumatic stress disorder and alcohol use disorder, one of 19 psychedelic studies the agency is funding through $23…
VA Launches MDMA Clinical Trial to Measure Effects on PTSD, Mental Health
The Department of Veterans Affairs (VA) on Tuesday announced a new clinical trial of methylenedioxymethamphetamine-assisted therapy, more commonly known as MDMA, to evaluate the safety and efficacy when treating current and former military personnel for severe mental health disorders including posttraumatic stress disorder (PTSD) and alcohol use disorder.
newsbudz.com
GrowCola.comVA Launches New Study On MDMA To Treat Veterans With PTSD And Alcohol Use Disorder
The U.S. Department of Veterans Affairs (VA) is launching a new trial on whether MDMA-assisted therapy can help military veterans who are struggling with severe mental health disorders, including PTSD and alcohol use disorder. The study will involve approximately 80 veterans and will compare outcomes between those who take MDMA and undergo psychotherapy and those in a control group who receive identical psychotherapy without the drug. "We need a…
Coverage Details
Bias Distribution
- 42% of the sources are Center
![[your]NEWS](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Ffb6dc495f74049f513563c33352175eaa0ecd509.jpg%3Fwidth%3D60&w=128&q=75)
Factuality
To view factuality data please Upgrade to Premium
